These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34538268)

  • 1. Expanding access to HIV services during the COVID-19 pandemic-Nigeria, 2020.
    Boyd AT; Jahun I; Dirlikov E; Greby S; Odafe S; Abdulkadir A; Odeyemi O; Dalhatu I; Ogbanufe O; Abutu A; Asaolu O; Bamidele M; Onyenuobi C; Efuntoye T; Fagbamigbe JO; Ene U; Fagbemi A; Tingir N; Meribe C; Ayo A; Bassey O; Nnadozie O; Boyd MA; Onotu D; Gwamna J; Okoye M; Abrams W; Alagi M; Oladipo A; Williams-Sherlock M; Bachanas P; Chun H; Carpenter D; Miller DA; Ijeoma U; Nwaohiri A; Dakum P; Mensah CO; Aliyu A; Oyeledun B; Okonkwo P; Oko JO; Ikpeazu A; Aliyu G; Ellerbrock T; Swaminathan M
    AIDS Res Ther; 2021 Sep; 18(1):62. PubMed ID: 34538268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiated service delivery models among PLHIV in Akwa Ibom and Cross River States, Nigeria during the COVID-19 pandemic: descriptive analysis of programmatic data.
    Sanwo O; Persaud NE; Nwaokoro P; Idemudia A; Akpan U; Toyo O; Imohi P; Badru T; Obiora-Okafo C; Uzochukwu CE; Aliu O; Olatunbosun K; Pandey SR; Khamofu H; Chiegil R; James E; Iyortim I; Oqua D; Bateganya M
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25820. PubMed ID: 34713591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protecting the gains: analysis of HIV treatment and service delivery programme data and interventions implemented in 19 African countries during COVID-19.
    Bachanas PJ; Chun HM; Mehta N; Aberle-Grasse J; Parris K; Sherlock MW; Lloyd S; Zeh C; Makwepa DK; Kapanda ML; Dokubo EK; Bonono L; Balachandra S; Ehui E; Fonjungo P; Nkoso AM; Mazibuko S; Okello VN; Tefera F; Getachew M; Katiku EM; Mulwa A; Asiimwe FM; Tarumbiswa TF; Auld AF; Nyirenda R; Dos Santos De Louvado AP; Gaspar I; Hong SY; Ashipala L; Obanubi C; Ikpeazu A; Musoni C; Yoboka E; Mthethwa S; Pinini Z; Bunga S; Rumunu J; Magesa DJ; Mutayoba B; Nelson LJ; Katureebe C; Agolory S; Mulenga LB; Nyika P; Mugurungi O; Ellerbrock T; Mitruka K
    J Int AIDS Soc; 2022 Nov; 25(11):e26033. PubMed ID: 36419346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of COVID-19 on multi-month dispensing (MMD) policies for antiretroviral therapy (ART) and MMD uptake in 21 PEPFAR-supported countries: a multi-country analysis.
    Bailey LE; Siberry GK; Agaba P; Douglas M; Clinkscales JR; Godfrey C
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25794. PubMed ID: 34713578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of antiretroviral therapy through private pharmacies and postal courier services during COVID-19 in Botswana: acceptability and reach of two out-of-facility individual differentiated service delivery models.
    Mpofu M; Moyo T; Gilbert M; Dikobe W; Nishimoto L; Katiko G; Batuka J; Satti H; Qambayot M; Mahler H; Kitso L; Marqusee H; Bateganya M
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25814. PubMed ID: 34713589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stakeholder efforts to mitigate antiretroviral therapy interruption among people living with HIV during the COVID-19 pandemic in China: a qualitative study.
    Sun Y; Zhan Y; Li H; Yuan T; Gao Y; Liang B; Feng A; Li P; Zheng W; Fitzpatrick T; Wu D; Zhai X; Zou H
    J Int AIDS Soc; 2021 Sep; 24(9):e25781. PubMed ID: 34473409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing community linkage to care and antiretroviral therapy Initiation: Lessons from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) and their adaptation in Nigeria ART Surge.
    Jahun I; Said I; El-Imam I; Ehoche A; Dalhatu I; Yakubu A; Greby S; Bronson M; Brown K; Bamidele M; Boyd AT; Bachanas P; Dirlikov E; Agbakwuru C; Abutu A; Williams-Sherlock M; Onotu D; Odafe S; Williams DB; Bassey O; Ogbanufe O; Onyenuobi C; Adeola A; Meribe C; Efuntoye T; Fagbamigbe OJ; Fagbemi A; Ene U; Nguhemen T; Mgbakor I; Alagi M; Asaolu O; Oladipo A; Amafah J; Nzelu C; Dakum P; Mensah C; Aliyu A; Okonkwo P; Oyeledun B; Oko J; Ikpeazu A; Gambo A; Charurat M; Ellerbrock T; Aliyu S; Swaminathan M
    PLoS One; 2021; 16(9):e0257476. PubMed ID: 34543306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid Scale-up of an Antiretroviral Therapy Program Before and During the COVID-19 Pandemic - Nine States, Nigeria, March 31, 2019-September 30, 2020.
    Dirlikov E; Jahun I; Odafe SF; Obinna O; Onyenuobi C; Ifunanya M; Efuntoye TA; Tingir N; Ene U; Fagbemi A; Meribe C; Bassey O; Ayo A; Fagbamigbe OJ; Amafah J; Bamidele M; Alagi M; Oladipo A; Dalhatu I; Okoye M; Onotu D; Gwamna J; Abrams WA; Conner DA; Nwaohiri A; Carpenter D; Ijeoma UC; Shah S; Tison LI; Shah M; Chun H; Williams-Sherlock M; Boyd AT; Bachanas P; Ikpeazu A; Aliyu GG; Ellerbrock T; Swaminathan M;
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(12):421-426. PubMed ID: 33764965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-Term Effects of the COVID-19 Pandemic on HIV Care Utilization, Service Delivery, and Continuity of HIV Antiretroviral Treatment (ART) in Haiti.
    Celestin K; Allorant A; Virgin M; Marinho E; Francois K; Honoré JG; White C; Valles JS; Perrin G; De Kerorguen N; Flowers J; Balan JG; Koama JBT; Barnhart S; Puttkammer N
    AIDS Behav; 2021 May; 25(5):1366-1372. PubMed ID: 33738698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with an interruption in treatment of people living with HIV in USAID-supported states in Nigeria: a retrospective study from 2000-2020.
    Tomescu S; Crompton T; Adebayo J; Kinge CW; Akpan F; Rennick M; Chasela C; Ondura E; Dauda DS; Pisa PT
    BMC Public Health; 2021 Nov; 21(1):2194. PubMed ID: 34847909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the COVID-19 pandemic on HIV service delivery and viral suppression: Findings from the SHARP program in Northern Nigeria.
    Mugo C; Adedokun O; Alo OD; Ezeokafor N; Adeyemi S; Kpamor Z; Madueke L; James E; Adebajo SB; Semo BW
    PLoS One; 2024; 19(4):e0300335. PubMed ID: 38564514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV service delivery in the time of COVID-19: focus group discussions with key populations in India.
    Pollard R; Gopinath U; Reddy YA; Kumar BR; Mugundu P; Vasudevan CK; Srikrishnan AK; Singh A; McFall AM; Mayer KH; Mehta SH; Solomon SS
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25800. PubMed ID: 34713583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerating HIV epidemic control in Benue state, Nigeria, 2019-2021: the APIN program experience.
    Jwanle P; Ibiloye O; Obaje M; Ngwoke K; Usha T; Amoo O; Ogunsola O; Okezie U; Olaitan R; Ofuche E; Onwuatuelo I; Samuels J; Fagbamigbe J; Nwagagbo F; Ogbanufe O; Okoye M; Okonkwo P
    Ther Adv Infect Dis; 2023; 10():20499361231153549. PubMed ID: 36814516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing multimonth dispensing of antiretrovirals and assessing the effect on viral load suppression among children and adolescents receiving HIV services in Nigeria.
    Casalini C; Bateganya M; Akolo C; Sanwo O; Idemudia A; Nwaokoro P; Eyam F; Ogbechie MD; Obiora-Okafo C; Oduola A; Wilcher R; Mack N; Khamofu H; Pandey SR
    PLoS One; 2023; 18(6):e0286303. PubMed ID: 37315075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief Report: Programmatic Scale-up of Tuberculosis Preventive Treatment Among People Living With HIV Through Targeted Technical Assistance to High-Volume Antiretroviral Treatment Sites-Nigeria, 2018-2019.
    Boyd AT; Odume B; Sidibe K; Onotu D; Ogbanufe O; Mgbakor I; Swaminathan M
    J Acquir Immune Defic Syndr; 2020 Dec; 85(4):450-453. PubMed ID: 33136743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEPFAR's response to the convergence of the HIV and COVID-19 pandemics in Sub-Saharan Africa.
    Golin R; Godfrey C; Firth J; Lee L; Minior T; Phelps BR; Raizes EG; Ake JA; Siberry GK
    J Int AIDS Soc; 2020 Aug; 23(8):e25587. PubMed ID: 32767707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ensuring Optimal Community HIV Testing Services in Nigeria Using an Enhanced Community Case-Finding Package (ECCP), October 2019-March 2020: Acceleration to HIV Epidemic Control.
    Jahun I; Dirlikov E; Odafe S; Yakubu A; Boyd AT; Bachanas P; Nzelu C; Aliyu G; Ellerbrock T; Swaminathan M;
    HIV AIDS (Auckl); 2021; 13():839-850. PubMed ID: 34471388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scale-up of antiretroviral treatment access among people living with HIV in Rivers State, Nigeria, 2019--2020.
    Boyd AT; Ogbanufe O; Onyenuobi C; Mgbakor I; Bachanas P; Olupitan O; Umeh C; Adegboye A; Owhonda G; Odafe S; Jahun I; Dakum P; Mensah C; Gwamna J; Onotu D; Dirlikov E; Williams-Sherlock M; Okolo C; Verinumbe T; Idakwo S; Kumtap MU; Ellerbrock T; Swaminathan M
    AIDS; 2021 Jun; 35(7):1127-1134. PubMed ID: 33946087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceleration of differentiated service delivery for HIV treatment in sub-Saharan Africa during COVID-19.
    Grimsrud A; Wilkinson L
    J Int AIDS Soc; 2021 Jun; 24(6):e25704. PubMed ID: 34105884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of COVID-19 on the HIV care continuum in Asia: Insights from people living with HIV, key populations, and HIV healthcare providers.
    Hung CC; Banerjee S; Gilada I; Green K; Inoue Y; Kamarulzaman A; Leyritana K; Phanuphak N; Wong T; Wong T; Singh S; Choi JY
    PLoS One; 2022; 17(7):e0270831. PubMed ID: 35857755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.